First-in-human study of MM-141: A novel tetravalent monoclonal antibody targeting IGF-1R and ErbB3.
Steven J. Isakoff
Consultant or Advisory Role - Merrimack Pharmaceuticals (U)
Mansoor N. Saleh
No relevant relationships to disclose
Alexey Lugovskoy
Employment or Leadership Position - Merrimack Pharmaceuticals
Stock Ownership - Merrimack Pharmaceuticals
Sara Manoli
Employment or Leadership Position - Merrimack Pharmaceuticals
Stock Ownership - Merrimack Pharmaceuticals
Akos Gabor Czibere
Employment or Leadership Position - Merrimack Pharmaceuticals
Stock Ownership - Merrimack Pharmaceuticals
Patricia LoRusso
No relevant relationships to disclose
Monica Arnedos
Consultant or Advisory Role - Merrimack Pharmaceuticals (U)
Honoraria - Novartis